India’s pharmaceutical industry has earned global recognition as a key player in the production of affordable generic medicines. As the “pharmacy of the world,” the country supplies over 50% of global demand for vaccines, 40% of generic demand in the United States, and 25% of all medicines in the United Kingdom. Despite these impressive statistics, the Indian pharmaceutical sector faces significant challenges related to drug quality, safety, and regulatory oversight. These issues highlight the urgent need for more stringent drug regulations in India to safeguard public health and maintain its reputation on the global stage. Current Regulatory Landscape India’s drug…